This suggests that PD-L1 expression in tumor cells develops via an extrinsic mechanism (i.e., adaptive immune resistance), in which tumoral PD-L1 expression is extrinsically derived in response to the expression of inflammatory cytokines (in particular, to interferon-γ that is released by CD8+ cytotoxic T cells) [44]. This evidence concerns the gene CD274 and neoplasm.